Biotech Incubator Business Models: Lessons and Needed Improvements

10:00 AM - 10:55 AM (JST), Wednesday, March 6, 2019 ・ 2nd Floor
Corporate biopharmas have decades of experience with university collaborations and open incubator models that produce research and pre-clinical data, but disappointingly few new medicines. What features of incubators create value and where should incubator business model innovation go next?
Alliance Manager & Senior Scientist
Open Innovation Center Japan, Bayer Yakuhin
Senior Director and APAC Lead, Search and Evaluation, Worldwide Business Development, Chief Business Office
Pfizer Inc